MedPath Search

Found 539135 clinical trials

Sort by:

Immediate Effects of Kinesio Taping in Primary Dysmenorrhea

Not Applicable

Recruiting

Conditions: Primary Dysmenorrhea

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Okan University

Target Recruit Count: 24

Registration Number: NCT06990815

Locations: 🇹🇷
Istanbul Okan University, Istanbul, Turkey

Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries

Not Applicable

Not yet recruiting

Conditions: Hypertension
Diabetes Mellitus
Neglected Tropical Diseases

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Universidad Peruana Cayetano Heredia

Target Recruit Count: 2094

Registration Number: NCT06989502

Locations: 🇲🇿
Eduardo Mondlane University, Maputo, Mozambique
🇳🇵
B.P. Koirala Institute of Health Sciences, Dharān Bāzār, Nepal
🇵🇪
Universidad Peruana Cayetano Heredia, Piura, Peru

A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis

Not Applicable

Not yet recruiting

Conditions: Psoriatic Arthritis (PsA)

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Dr. Schär AG / SPA

Target Recruit Count: 60

Registration Number: NCT06990152

Locations: 🇮🇹
ASST Gaetano Pini CTO, UOC Clinica Reumatologica, Milano, Italy

Musically-Guided Paced Breathing Intervention Improves Mental Health in War-Affected Adolescents: A Randomized Trial

Not Applicable

Completed

Conditions: Anxiety
Self-Efficacy
Depression Not Otherwise Specified

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Muvik Labs

Target Recruit Count: 220

Registration Number: NCT06988800

Locations: 🇵🇸
MECI, Deir Ghassaneh, West Bank, Palestinian Territory, occupied

Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study

Not Applicable

Completed

Conditions: ACL Rupture

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: SACIMEX

Target Recruit Count: 36

Registration Number: NCT06990100

Locations: 🇫🇷
Clinique MEDIPOLE GARONNE, Toulouse, France

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Phase 2

Not yet recruiting

Conditions: IgAN
C3G
Complement-mediated Kidney Disease

Interventions: Drug: ADX-038

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: ADARx Pharmaceuticals, Inc.

Target Recruit Count: 30

Registration Number: NCT06989359

Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement

Not Applicable

Not yet recruiting

Conditions: Pain

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 86

Registration Number: NCT06991075

Locations: 🇺🇸
MUSC Women's Health- Cannon Street, Charleston, South Carolina, United States

The Effect of the Flipped Learning Model on Nurses' Evidence-based Practice Competence

Not Applicable

Completed

Conditions: Evidence Based Practice
Flipped Education Model

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Istanbul University - Cerrahpasa

Target Recruit Count: 19

Registration Number: NCT06988878

Locations: 🇹🇷
Prof. Dr. Cemil Taşcıoğlu Training and Research Hospital, Istanbul, Turkey

COVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)

Completed

Conditions: COVID-19
COVID-19 Serological Testing
COVID-19 Vaccines
Health Personnel
Antibodies, Viral
Seroepidemiologic Studies

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: Centre Hospitalier de Saint-Denis

Target Recruit Count: 447

Registration Number: NCT06989307

Locations: 🇫🇷
France, Saint-Denis, France

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

Phase 2

Recruiting

Conditions: Esophageal Squamous Cell Carcinoma

Interventions: Drug: Nimotuzumab
Radiation: radiotherapy
Drug: Tegafur

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 95

Registration Number: NCT06988956

Locations: 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, China